Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.41893 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.36915 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.36869 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.6958 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32086 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.38613 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.40436 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.34376 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.34179 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72714 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.36418 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35679 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.37378 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.35538 | 15 |